mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
SNX-2112 |
CTRPv2 |
pan-cancer |
AAC |
0.0096 |
0.8 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0099 |
0.8 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.8 |
mRNA |
MGCD-265 |
CTRPv2 |
pan-cancer |
AAC |
-0.01 |
0.8 |
mRNA |
ML258 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
etomoxir |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.8 |
mRNA |
CIL55 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.8 |